Cerebral palsy and placental infection: a case-cohort study
© Vigneswaran et al 2004
Received: 08 September 2003
Accepted: 27 January 2004
Published: 27 January 2004
Skip to main content
© Vigneswaran et al 2004
Received: 08 September 2003
Accepted: 27 January 2004
Published: 27 January 2004
The association between cerebral palsy in very preterm infants and clinical, histopathologic and microbiological indicators of chorioamnionitis, including the identification of specific micro-organisms in the placenta, was evaluated in a case-cohort study.
Children with a diagnosis of cerebral palsy at five years of age were identified from amongst participants in a long-term follow-up program of preterm infants. The comparison group was a subcohort of infants randomly selected from all infants enrolled in the program. The placentas were examined histopathologically for chorioamnionitis and funisitis, and the chorioamnionic interface was aseptically swabbed and comprehensively cultured for aerobic and anaerobic bacteria, yeast and genital mycoplasmas. Associations between obstetric and demographic variables, indicators of chorioamnionitis and cerebral palsy status were examined by univariate analysis.
Eighty-two infants with cerebral palsy were compared with the subcohort of 207 infants. Threatened preterm labor was nearly twice as common among the cases as in the subcohort (p < 0.01). Recorded clinical choroamnionitis was similar in the two groups and there was no difference in histopathologic evidence of infection between the two groups. E. coli was cultured from the placenta in 6/30 (20%) of cases as compared with 4/85 (5%) of subcohort (p = 0.01). Group B Streptococcus was more frequent among the cases, but the difference was not statistically significant.
The association between E. coli in the chorioamnion and cerebral palsy in preterm infants identified in this study requires confirmation in larger multicenter studies which include microbiological study of placentas.
The rate of cerebral palsy amongst neonatal survivors born below 33 weeks is up to 30 times higher than among those born at term [1, 2]. The etiology of this condition is poorly understood and current research focuses on the prenatal period. A number of epidemiologic studies have reported a relationship between maternal clinical chorioamnionitis and neurologic damage among very low birthweight infants [3–10]. This correlation is corroborated by experimental data .
Although most prior studies have used non-specific clinical measures of chorioamnionitis to provide retrospective information on infection , studies linking histopathologic indicators of chorioamnionitis with cerebral palsy point to infection of the chorioamnion as a potential cause. Investigations into the etiology of cerebral palsy among surviving very preterm infants have rarely examined the microbiology of the chorioamnion. Knowledge of the specific microorganisms involved is essential before preventive strategies such as screening and treatment of infection during pregnancy can be developed. This study examines clinical, histopathologic and microbiological indicators of chorioamnionitis, including the identification of specific micro-organisms in the placenta as risk factors for cerebral palsy among preterm infants.
A case-cohort study was conducted using the Women's and Children's Hospital (Adelaide, Australia) long-term follow-up program for the years 1984 to 1994. The case-cohort study design provides the advantages of a cohort study in that it allows the direct calculation of a risk ratio without either a rare disease assumption or, as in this case, the collection of full information on every member of a cohort. All cases of the condition of interest that arise within a defined cohort comprise the case group. Their exposure experience is compared with that of a randomly selected subset of the entire cohort. Thus exposure data in this study were ascertained on all cases of cerebral palsy and a subset of all preterm infants enrolled in the longterm follow-up program. The case-cohort study design allows for the efficient investigation of all cases of cerebral palsy within the target cohort and a sample of infants enrolled in the longterm follow-up program, without losing the advantage provided by the direct measurement of risk of cerebral palsy associated with placental infection, which would be assessed in a cohort study .
Pre-term infants are registered in the long-term follow-up program by hospital staff. Criteria for registration have changed over time; infants registered prior to 1992 had birthweights ≤ 1500 grams. After 1992, only infants born at ≤ 29 weeks gestation or ≤ 1000 grams were eligible for long-term follow-up. This study only included infants enrolled in the program between 1984 and 1994 to ensure that sufficient calendar time had elapsed for all of them to undergo neuro-developmental assessment at five years of age.
Cerebral palsy was determined by assessment by a paediatrician and physiotherapist with expertise in neuro-development. In the Long-Term Follow-Up Unit, cerebral palsy is defined as disorder of movement and posture occurring due to central problems of the brain and is of early childhood onset; there should be some objective motor signs present – such as alteration of muscle tone, deep tendon reflexes or persistent puncture reflexes, alteration of balance and control and, in some individuals, presence of involuntary movements; other progressive neuromuscular disorders or insult to the brain that was acquired after 2 years of age were excluded. Every child diagnosed by neuro-developmental assessment at five years of age as having cerebral palsy and for whom antenatal data were available, was included as a case. If there was no diagnosis at 5 years of age, then a diagnosis of moderate or severe cerebral palsy at either three or four years of age was accepted. If a diagnosis was made at two years of age or less that was not confirmed at a later age, the child was not included as a case. Any child with a diagnosis of minimal cerebral palsy was excluded. Of 143 originally identified on the database we excluded children with a minimal diagnosis, two who were adopted, 12 retrievals who had no antenatal data, and 20 with a diagnosis of mild CP before 24 months of age that was not confirmed subsequently and two who were syndromic.
The comparison group was a subcohort randomly selected from the long term follow-up data base regardless of case status and covariate status and with antenatal data available (24 cases were also included in the sub-cohort). A random sample generator in Microsoft Excel was used to generate the subcohort selecting based on unit record number, which is a unique identifier for each infant. The subcohort was selected to represent the distribution of infants entered onto the Growth and Development Unit database under the two different admission criteria. A total of 1207 infants were admitted to the Growth and Development Program at the Women's and Children's Hospital between 1984 and 1994. Between 1984 and 1991, 920 (76%) infants were admitted to the Long Term Follow-Up Program under the selection criterion of weighing <1500 g at birth. Between 1992 and 1994, 287 (24%) infants were admitted to the Growth and Development Unit under the selection criteria of ≤ 29 weeks gestational age or <1000 g at birth. Of the 240 infants selected for the subcohort, 182 (76%) were born between 1984 and 1991, while 58 (24%) were born between 1992 and 1994. Following the exclusion of children who were adopted and those who were transferred in, 207 infants were available for analysis.
Demographic, obstetric and laboratory data were collected from case note review and hospital databases. Obstetric data included threatened preterm labor which is defined as preterm labor that is subsequently suppressed and does not result in delivery. Placental swabs for microbiology were obtained aseptically by histopathology staff from the chorioamnionic membrane interface from 30 cases and 85 subcohort, and cultured for aerobic and anaerobic bacteria, yeasts and genital mycoplasmas, according to hospital guidelines which specified that placentas from gestations less than 34 weeks should be submitted for pathological examination [13, 14]. Placental examination was performed in 54 (65%) cases and 150 (72%) subcohort. These slides were reviewed in 2001 by a histopathologist blinded to the cerebral palsy outcome and acute chorioamnionitis and funisitis were diagnosed using standard criteria .
Univariate analyses were undertaken examining associations between obstetric and demographic characteristics, clinical, histopathologic and microbiological indicators of chorioamnionitis and cerebral palsy status. Results of multivariable analyses are not presented. Given the complexity of causal pathways to cerebral palsy involving preterm birth , we considered it inappropriate to adjust (other than by stratified sampling), for gestation, which may be both an independent cause of cerebral palsy and on the pathway from infection to cerebral palsy.
Demographic and obstetric characteristics of study population
Cases n (%)
Sub-Cohort n (%)
Relative risk (95% Confidence Intervals)
0.81 [0.55, 1.19]
Threatened preterm labor
1.82 [1.21, 2.73]
0.69 [0.36, 1.30]
Severe intra-uterine growth restriction (as in casenotes)
1.00 [0.61, 1.64]
1.37 [0.83, 2.24]
Preterm prelabor rupture of the membranes
1.02 [0.71, 1.48]
1.53 [0.83, 2.83]
1.04 [0.72, 1.49]
Mode of delivery
Normal vaginal delivery
0.83 [0.56, 1.24]
1.08 [0.60, 1.94]
Gestational age at delivery
≤ 27 weeks
1.87 [0.94, 3.70]
1.47 [0.75, 2.85]
≥ 32 weeks
Gestational age at delivery weeks, median (inter-quartile range)
0.93 [0.86, 1.00]a
Birthweight, grams, median (inter-quartile range)
0.93 [0.87, 0.99]b
0.77 [0.49, 1.20]
1.30 [0.90, 1.89]
Indicators of chorioamnionitis: clinical, histologic and microbiological
Relative risk (95% Confidence Intervals)
n = 82
n = 207
Recorded clinical chorioamnionitis
0.94 [0.54, 1.64]
Maternal fever a
1.26 [0.84, 1.87]
1.13 [0.69, 1.82]
0.78 [0.48, 1.26]
0.87 [0.51, 1.49]
Elevated maternal C-reactive protein (>6 mg/L) /no. tested
29 /38 (76%)
49 /78 (63%)
1.75 [0.93, 3.30]
Abnormal maternal whiteblood count >15,000 × 10 6 /L/no. tested
55 /70 (79%)
114 /159 (72%)
1.37 [0.85, 2.23]
1.45 [0.97, 2.18]
n = 30
n = 85
One or more isolates
1.05 [0.56, 1.96]
Group B Streptococcus
1.85 [0.86, 3.97]
2.35 [1.27, 4.34]
1.54 [0.62, 3.84]
0.66 [0.23, 1.90]
0.79 [0.32, 1.97]
n = 54
n = 150
1.19 [0.76, 1.88)
n = 54
n = 144
1.35 [0.83, 2.21]
Our investigation explored the relationship between micro-organisms in the chorioamnion and cerebral palsy in survivors of preterm birth. This strategy provides the next step in identifying the causative pathway between infection and cerebral palsy. A previous report  of six children with cerebral palsy showed an association, that was not confirmed by our study, between coagulase negative staphylococci in the chorioamnion space and cerebral palsy. Of interest, in that study E. coli was isolated in the chorioamnion of 2/5 (40%) cerebral palsy cases compared with 12/102 (11.8%) controls; when we reanalysed their data we found an Odds Ratio of 5.00 (95%CI [0.37, 47.36] p = 0.13).
The strength of this study is the investigation for specific micro-organisms in the chorioamnion using aseptic technique by trained scientists as part of routine hospital management of preterm births. Two important aspects of our study are: 1) the aseptic sampling method used to swab the chorio-amnionic membrane interface. It should be noted that if the maternal placental surface, instead of the sub-amnion, is swabbed, vaginal micro-organisms which contaminate the surface during removal, will be recovered; 2) the comprehensive microbiological culture methods used to recover aerobic and anaerobic bacteria, yeasts and genital mycoplasmas. These are costly and time-consuming but provide valuable information not obtainable in other ways. Furthermore, the study involved detailed five-year follow up of very low birthweight infants with near complete case ascertainment.
Some limitations of this study include: retrospective review of data collected for clinical management over a long period; lack of information about antenatal and postnatal steroid therapy; and lack of placental data on some subjects, which reduced the effective sample size for microbiological analysis to 30 cases and 85 subcohort. These data were available on a similar proportion of cases and the comparison sub-cohort. Although our hospital guidelines for the submission of placentas for pathological examination specify all placentas less than 34 weeks should be examined, for a variety of reasons, only a proportion of those placentas that meet the criteria for examination are actually submitted , a problem that is not unique to our institution [19–21]. Microbiological examination was not usually performed where there was a compelling reason for the preterm delivery, such as severe early onset pre-eclampsia. Nonetheless, it is possible that with a substantial level of missing data, a bias may have been introduced in the comparison of microbiological profiles between cases and the subcohort. Such bias could be responsible for the different associations observed between the small studies published to date. The 25% positive culture rate from placentas without histochorioamnionitis is similar to other studies with comprehensive culture including genital mycoplasmas. Hillier et al found higher culture positive rates in preterm women (44%) than term women without histological chorioamnionitis (13%). Two previous reports [23, 24] found 12% and 15% positive respectively but did not perform culture for genital mycoplasmas. In addition 29% of the latter study were at term. This study, nevertheless, has a number larger than most previously reported studies in such a population .
The strong association between threatened preterm labor and cerebral palsy is important to note and may have significant ramifications for obstetric management of threatened preterm labor. We postulate women with threatened preterm labour who do not deliver within a proximate time may be at significant risk of delivering an infant with cerebral palsy, perhaps through continuing fetal exposure to infection or activation of cytokines involved in the labor process.
In our study the presence of E. coli in the chorioamnion was significantly associated with cerebral palsy. This link is supported by experimental studies in a rabbit model, which showed that white matter damage in the fetal brain can be induced by E. coli amnionitis . Histological chorioamnionitis was found in two of four (50%) cases and one of two (50%) subcohort with E. coli in the chorioamnion compared with 20/50 (40%) and 55/149 (37%) respectively in E. coli negative chorioamnions but this difference was not significant. However, histological chorioamnionitis may sometimes be absent and varies with the intensity and duration of infection .
In the light of the recent hypothesis  that bacterial vaginosis is associated with cerebral palsy, we analysed the data for Bacteroides spp. Although Bacteroides spp. were more common among cerebral palsy cases, this was not statistically significant. Although Ureaplasma spp. are generally the most common placental isolates found in chorioamnionitis, in our study Ureaplasma spp. were not more frequent among cerebral palsy cases. A recent study  linked U. urealyticum in placentas with chorioamnionitis and fetal vasculitis, but not in VLBW infants with cerebral echolucencies. This suggests that other organisms, such as E. coli, may be more important and that the reason histologic chorioamnionitis itself does not directly predict brain injury is because much of it is caused by U. urealyticum. Group B Streptococcus in the chorioamnion was twice as common in cases as in the subcohort; however, the long-standing hospital protocol of antibiotic prophylaxis in labor for group B Streptococcal carriers may have contributed to the lower total number of group B Streptococcal placental isolates.
In a study of 2646 women in labor, vaginal colonisation with E. coli was associated with preterm delivery and low birthweight . These findings, together with our data linking E. coli and cerebral palsy, suggest the need for investigation and identification of E. coli in the genital tract in women with threatened preterm labor. The benefits and disadvantages of antibiotic therapy should then be considered.
This report of chorioamnionic E. coli infection in cerebral palsy cases gives insight into pathogenesis of infection and cerebral palsy and indicates the value of microbiological study of placentas in extremely preterm deliveries. Confirmation of our findings in a large prospective multicenter study is essential considering that this vital information may elucidate understanding of causative pathways for cerebral palsy.
We are grateful to K. Willson for statistical analysis. We thank J.S Robinson for advice and H.M Chambers for establishing a system of routine placental analysis, which has made this study possible. This study was supported by the Perinatal Pathology Research Fund of the Women's and Children's Hospital, Adelaide.
This article is published under license to BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL.